Government of India (GoI) and the major pharmaceutical industry organisations have come together to form the India – Responsible Healthcare Trust to power the Brand India Pharma campaign. A one of its kind public-private partnership, the formation of the Trust represents the commitment to both drive and safeguard the interests of the Indian pharma industry.
The Trust chaired by the Commerce Secretary comprises key stakeholders, namely, the Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers’ Association (IDMA), Bulk Drug Manufacturers Association (BDMA), Association of Biotechnology Led Enterprises (ABLE), Pharmaceutical Export Promotion Council of India (Pharmexcil) and India Brand Equity Foundation (IBEF). The Trust aims to combine both financial and non-financial resources towards a common agenda. The Trust aims to create better awareness and develop an informed perspective about Brand India Pharma in both the domestic and global markets.
“The India – Responsible Healthcare Trust will spearhead the Brand India Pharma initiative through the second phase. The industry-government partnership is an important milestone in the campaign,” said Rajeev Kher, Commerce Secretary, Government of India.
The Brand India Pharma campaign was launched under the aegis of the Department of Commerce at CPhI Japan in March 2012. The Brand India Pharma showcase has made its presence felt at prestigious events like CPhI Worldwide consistently over the past two years. The Department of Commerce along with IBEF and Pharmexcil has invested huge resources with measurable and impacting results in the first phase of the Brand India Pharma campaign.
The India – Responsible Healthcare Trust is expected to take the Brand India Pharma campaign to the next level. The primary objective of this Trust will be to position India as a Responsible Healthcare provider.
EP News Bureau- Mumbai